ANIX vs DOW · $101.1M cap vs P/E 74, rev $39.97B
Anixa Biosciences Inc (ANIX) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
Anixa Biosciences Inc (ANIX) is a biotechnology company listed on US.
Dow Inc (DOW) is a chemicals company listed on US.
ANIX does not have a complete income-statement cache yet.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
ANIX currently screens at market cap $101.1M. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the ANIX and DOW stock pages for the full models.
Not investment advice.